EVAXION BIOTECH A/S (EVAX) Stock Price, Quote, News and Overview

What is the stock price of EVAXION BIOTECH A/S today?

The current stock price of EVAX is 1.49 USD. The price increased by 2.76% in the last trading session.

What is the ticker symbol for EVAXION BIOTECH A/S stock?

The exchange symbol of EVAXION BIOTECH A/S is EVAX and it is listed on the Nasdaq exchange.

On which exchange is EVAX stock listed?

EVAX stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for EVAXION BIOTECH A/S stock?

8 analysts have analysed EVAX and the average price target is 32.56 USD. This implies a price increase of 2084.9% is expected in the next year compared to the current price of 1.49. Check the EVAXION BIOTECH A/S stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is EVAXION BIOTECH A/S worth?

EVAXION BIOTECH A/S (EVAX) has a market capitalization of 9.41M USD. This makes EVAX a Nano Cap stock.

How many employees does EVAXION BIOTECH A/S have?

EVAXION BIOTECH A/S (EVAX) currently has 46 employees.

What are the support and resistance levels for EVAXION BIOTECH A/S (EVAX) stock?

EVAXION BIOTECH A/S (EVAX) has a support level at 1.3 and a resistance level at 1.55. Check the full technical report for a detailed analysis of EVAX support and resistance levels.

Is EVAXION BIOTECH A/S (EVAX) expected to grow?

The Revenue of EVAXION BIOTECH A/S (EVAX) is expected to grow by 1.47% in the next year. Check the estimates tab for more information on the EVAX EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy EVAXION BIOTECH A/S (EVAX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of EVAX, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of EVAX, evaluating the profitability, health, valuation and growth aspects
• EVAXION BIOTECH A/S (EVAX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• EVAXION BIOTECH A/S (EVAX) Sales and EPS estimates to see what analysts future expectations are.
• EVAXION BIOTECH A/S (EVAX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• EVAXION BIOTECH A/S (EVAX) Insider and Institutional Ownership to learn about the owners and their transactions.
• EVAXION BIOTECH A/S (EVAX) Stock Chart to make your own analysis
• EVAXION BIOTECH A/S (EVAX) Latest news and press-releases to stay up to date.

Does EVAXION BIOTECH A/S (EVAX) stock pay dividends?

EVAX does not pay a dividend.

When does EVAXION BIOTECH A/S (EVAX) report earnings?

EVAXION BIOTECH A/S (EVAX) will report earnings on 2025-05-26.

What is the Price/Earnings (PE) ratio of EVAXION BIOTECH A/S (EVAX)?

The PE ratio for EVAXION BIOTECH A/S (EVAX) is 2.37. This is based on the reported non-GAAP earnings per share of 0.63 and the current share price of 1.49 USD. Check the full fundamental report for a full analysis of the valuation metrics for EVAX.

What is the Short Interest ratio of EVAXION BIOTECH A/S (EVAX) stock?

The outstanding short interest for EVAXION BIOTECH A/S (EVAX) is 0.39% of its float. Check the ownership tab for more information on the EVAX short interest.

ChartMill assigns a fundamental rating of 2 / 10 to EVAX. EVAX has a bad profitability rating. Also its financial health evaluation is rather negative.

Over the last trailing twelve months EVAX reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 107.68% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to EVAX. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -574.38% and a revenue growth 1.47% for EVAX